Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 326

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 16J
Chunk 326
---
ITEM 16J. INSIDER TRADING POLICIES

We haveadopted a statement of trading policiesthat governs the trading in our securities by our directors, officers, employees and certain other covered persons, and which is reasonably designed to promote compliance with applicable insider trading laws, rules and regulations, and the Nasdaq Rules. A copy of the Insider Trading Policy is included as Exhibit 11.1 to this Annual Report on Form 20-F. In addition, with regard to any trading in our own securities, it is our policy to comply with the federal securities laws and the applicable exchange listing requirements.

ITEM 16K. CYBERSECURITY